These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 30852635

  • 21. [Tacrolimus ointment in the management of atopic keratoconjunctivitis].
    Benaim D, Tétart F, Bauvin O, Delcampe A, Joly P, Muraine M, Gueudry J.
    J Fr Ophtalmol; 2019 May; 42(5):435-440. PubMed ID: 30935698
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: a retrospective study.
    Virtanen HM, Reitamo S, Kari M, Kari O.
    Acta Ophthalmol Scand; 2006 Oct; 84(5):693-5. PubMed ID: 16965503
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Topical Tacrolimus for Chronic Allergic Conjunctival Disease with and without Atopic Dermatitis.
    Shoji J, Ohashi Y, Fukushima A, Miyazaki D, Uchio E, Takamura E, Fujishima H, Namba K, Kumagai N, Ebihara N, Okamoto S.
    Curr Eye Res; 2019 Jul; 44(7):796-805. PubMed ID: 30947551
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
    Ebihara N, Ohashi Y, Uchio E, Okamoto S, Kumagai N, Shoji J, Takamura E, Nakagawa Y, Nanba K, Fukushima A, Fujishima H.
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
    [Abstract] [Full Text] [Related]

  • 31. Tacrolimus ointment in the treatment of eyelid dermatitis.
    Freeman AK, Serle J, VanVeldhuisen P, Lind L, Clarke J, Singer G, Lebwohl M.
    Cutis; 2004 Apr; 73(4):267-71. PubMed ID: 15134327
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Topical tacrolimus for the treatment of severe allergic keratoconjunctivitis in children.
    Liendo VL, Vola ME, Barreiro TP, Wakamatsu TH, Gomes JÁP, Santos MSD.
    Arq Bras Oftalmol; 2017 Apr; 80(4):211-214. PubMed ID: 28954018
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Safety and efficacy of topical tacrolimus 0.03% in the management of vernal keratoconjunctivitis: a non-randomized controlled clinical trial.
    Eltagoury M, Abou Samra W, Ghoneim E.
    Med Hypothesis Discov Innov Ophthalmol; 2022 Apr; 11(2):52-63. PubMed ID: 37641784
    [Abstract] [Full Text] [Related]

  • 38. Vernal keratoconjunctivitis: Result of a novel therapy with 0.1% topical ophthalmic FK-506 ointment.
    Vichyanond P, Tantimongkolsuk C, Dumrongkigchaiporn P, Jirapongsananuruk O, Visitsunthorn N, Kosrirukvongs P.
    J Allergy Clin Immunol; 2004 Feb; 113(2):355-8. PubMed ID: 14767456
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.